Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1132405

Proposition of a new allosteric binding site for potential SARS-CoV-2 3CL protease inhibitors by utilizing molecular dynamics simulations and ensemble docking


Novak, Jurica; Rimac, Hrvoje; Kandagalla, Shivananda; Pathak, Prateek; Naumovich, Vladislav; Grishina, Maria; Potemkin, Vladimir
Proposition of a new allosteric binding site for potential SARS-CoV-2 3CL protease inhibitors by utilizing molecular dynamics simulations and ensemble docking // Journal of biomolecular structure & dynamics, 40 (2022), 19; 9347-9360 doi:10.1080/07391102.2021.1927845 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1132405 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Proposition of a new allosteric binding site for potential SARS-CoV-2 3CL protease inhibitors by utilizing molecular dynamics simulations and ensemble docking

Autori
Novak, Jurica ; Rimac, Hrvoje ; Kandagalla, Shivananda ; Pathak, Prateek ; Naumovich, Vladislav ; Grishina, Maria ; Potemkin, Vladimir

Izvornik
Journal of biomolecular structure & dynamics (0739-1102) 40 (2022), 19; 9347-9360

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
3CL protease ; molecular dynamics ; SARS-CoV-2 ; radotinib ; nilotinib

Sažetak
The SARS-CoV-2 3CL protease (3CLpro) shows a high similarity with 3CL proteases of other beta- coronaviruses, such as SARS and MERS. It is the main enzyme involved in generating various non- structural proteins that are important for viral replication and is one of the most important proteins responsible for SARS-CoV-2 virulence. In this study, we have conducted an ensemble docking of molecules from the DrugBank database using both the crystallographic structure of the SARS-CoV-2 3CLpro, as well as five conformations obtained after performing a cluster analysis of a 300 ns molecular dynamics (MD) simulation. This procedure elucidated the inappropriateness of the active site for non-covalent inhibitors, but it has also shown that there exists an additional, more favorable, allosteric binding site, which could be a better target for non-covalent inhibitors, as it could prevent dimerization and activation of SARS- CoV-2 3CLpro. Two such examples are radotinib and nilotinib, tyrosine kinase inhibitors already in usefor treatment of leukemia and which binding to the newly found allosteric binding site was also confirmed using MD simulations.

Izvorni jezik
Engleski

Znanstvena područja
Kemija, Interdisciplinarne prirodne znanosti, Farmacija



POVEZANOST RADA


Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb

Profili:

Avatar Url Hrvoje Rimac (autor)

Avatar Url Jurica Novak (autor)

Poveznice na cjeloviti tekst rada:

doi www.tandfonline.com

Citiraj ovu publikaciju:

Novak, Jurica; Rimac, Hrvoje; Kandagalla, Shivananda; Pathak, Prateek; Naumovich, Vladislav; Grishina, Maria; Potemkin, Vladimir
Proposition of a new allosteric binding site for potential SARS-CoV-2 3CL protease inhibitors by utilizing molecular dynamics simulations and ensemble docking // Journal of biomolecular structure & dynamics, 40 (2022), 19; 9347-9360 doi:10.1080/07391102.2021.1927845 (međunarodna recenzija, članak, znanstveni)
Novak, J., Rimac, H., Kandagalla, S., Pathak, P., Naumovich, V., Grishina, M. & Potemkin, V. (2022) Proposition of a new allosteric binding site for potential SARS-CoV-2 3CL protease inhibitors by utilizing molecular dynamics simulations and ensemble docking. Journal of biomolecular structure & dynamics, 40 (19), 9347-9360 doi:10.1080/07391102.2021.1927845.
@article{article, author = {Novak, Jurica and Rimac, Hrvoje and Kandagalla, Shivananda and Pathak, Prateek and Naumovich, Vladislav and Grishina, Maria and Potemkin, Vladimir}, year = {2022}, pages = {9347-9360}, DOI = {10.1080/07391102.2021.1927845}, keywords = {3CL protease, molecular dynamics, SARS-CoV-2, radotinib, nilotinib}, journal = {Journal of biomolecular structure and dynamics}, doi = {10.1080/07391102.2021.1927845}, volume = {40}, number = {19}, issn = {0739-1102}, title = {Proposition of a new allosteric binding site for potential SARS-CoV-2 3CL protease inhibitors by utilizing molecular dynamics simulations and ensemble docking}, keyword = {3CL protease, molecular dynamics, SARS-CoV-2, radotinib, nilotinib} }
@article{article, author = {Novak, Jurica and Rimac, Hrvoje and Kandagalla, Shivananda and Pathak, Prateek and Naumovich, Vladislav and Grishina, Maria and Potemkin, Vladimir}, year = {2022}, pages = {9347-9360}, DOI = {10.1080/07391102.2021.1927845}, keywords = {3CL protease, molecular dynamics, SARS-CoV-2, radotinib, nilotinib}, journal = {Journal of biomolecular structure and dynamics}, doi = {10.1080/07391102.2021.1927845}, volume = {40}, number = {19}, issn = {0739-1102}, title = {Proposition of a new allosteric binding site for potential SARS-CoV-2 3CL protease inhibitors by utilizing molecular dynamics simulations and ensemble docking}, keyword = {3CL protease, molecular dynamics, SARS-CoV-2, radotinib, nilotinib} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font